Navigation Links
Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
Date:3/28/2008

o fast-scan cyclic voltammetry in anesthetized rats. A stimulation train was delivered to the ventral tegmental area every five minutes and the resultant dopamine and rate of reuptake were measured. Peak concentrations of dopamine and the rate of dopamine reuptake were monitored in response to intraperitoneal injections of MSI-1436, saline or nomafensine (a known inhibitor of DAT). Post-hoc analyses indicated that the peak dopamine concentration and the rate of dopamine reuptake (tau) significantly increased from baseline only after injection with nomifensine and that neither MSI-1436 nor the saline control had an effect on these measurements.

"These studies serve to further confirm the selectivity of MSI-1436 as an inhibitor of PTP-1B and addresses one of the critical issues involved in the development of anti-obesity drugs," states Jack Armstrong, President and Chief Executive Officer of Genaera. "The low addictive potential of MSI-1436 further differentiates it from many other drug candidates in development. While MSI- 1436 is being developed to treat both type 2 diabetes and obesity, we believe it is essential to demonstrate that the side effects seen in other weight-loss only drugs are not observed with MSI-1436. We continue to differentiate MSI- 1436 from other drugs for anti-obesity and anti-diabetes indications through our preclinical studies and look forward to reporting additional supportive clinical data later this year."

The researchers included Dr. Roitman and Seth A. Wescott from the University of Illinois at Chicago, as well as Michael P. McLane, Ph.D. and Henry R. Wolfe, Ph.D. from Genaera.

About Genaera

Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefine the treatment paradigm for obesity and type 2 diabetes and is presently in a Phase 1 tria
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
3. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
4. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
5. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
6. Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436)
7. Genaera Announces Diabetes IND In Effect for Trodusquemine (MSI-1436)
8. Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at Keystone Symposia
9. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
10. CEL-SCI Corporation Releases Letter to Shareholders
11. Alfacell Corporation to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Reportlinker.com announces that a new market ... Global Orthopedic Soft Tissue Repair Devices Market ... About Orthopedic Soft Tissue Repair Devices ... that connect, support, or surround bones. There are ... tendons, ligaments, cartilage, fascia, and other fibrous tissues. ...
(Date:8/27/2014)... According to the new ... Dental Chairs, Dental Lasers), Current Trends, Opportunities - Global ... Equipment Market is expected to reach $7,138.9 million ... at a CAGR of 5.7% between 2014 and ... and 61 figures spread through 167 pages and ...
(Date:8/27/2014)... Conn. , Aug. 27, 2014 Pulse ... Record (EHR) , Practice Management , and Revenue ... little known business practices performed by some RCM vendors, at ... Philadelphia, PA on September 19-20, 2014.  ... Systems will return in September with a new session encouraging ...
Breaking Medicine Technology:Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 5Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 2Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 3Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 4
... SPRING, Md., Oct. 7, 2011 The U.S. Food ... a fixed-dose combination (FDC) prescription medication that contains two ... adults who need both sitagliptin and simvastatin. ... people in the United States have type 2 diabetes, ...
... BEIJING and NEW YORK, Oct. 6, 2011 /PRNewswire-Asia-FirstCall/ -- ... the "Company"), one of the leading plasma-based biopharmaceutical companies ... changes in its board of directors. On ... positions as a director of China Biologic, a member ...
Cached Medicine Technology:FDA Approves Combination Therapy Juvisync 2FDA Approves Combination Therapy Juvisync 3China Biologic Announces Changes in Directors 2China Biologic Announces Changes in Directors 3China Biologic Announces Changes in Directors 4
(Date:8/27/2014)... Top 10 Best SEO Hosting, a well-known ... suppliers and announced iPage, Bluehost and GoDaddy are the most ... and Europe to buy useful hosting (including VPS and cloud ... iPage has been serving hosting small business websites ... grown into a leader in the hosting industry for its ...
(Date:8/27/2014)... Skirt Sports , the innovative women’s ... pioneer runner, Kathrine Switzer, most noted for her brave running ... a line of women’s running clothes that unites the history ... 261 Fearless Movement. , “It is such an ... DeBoom. “Kathrine is the original Skirt – she stood ...
(Date:8/27/2014)... 27, 2014 The Latinos In Action ... and 7th at the Florida State Fair Grounds from ... Latino art and cultures from around the world. Latinos ... sponsor Go Smart Mobile and Univision Mobile, a service ... expecting an estimate of 4,000 people from different backgrounds, ...
(Date:8/27/2014)... Calif. (PRWEB) August 27, 2014 Seventy-three ... of Pharmacy (SoP) celebrated the beginning of their careers ... on Saturday, August 23. Students entering a four-year PharmD ... and care ?to welcome them into the profession as ... the ceremony held at the Garrison Theater in Claremont, ...
(Date:8/27/2014)... Dennis Thompson HealthDay ... Someone who has been mugged in a dark alley will ... with a fear of being attacked. But neuroscientists working ... how memories are linked with positive and negative emotions. And ... emotions attached to a memory. In essence, they made ...
Breaking Medicine News(10 mins):Health News:Well-known SEO Hosts Review Site Top10BestSEOHosting.com Recommends iPage, Bluehost and GoDaddy To Webmasters 2Health News:Skirt Sports Launches Clothing Line with Legendary Runner Kathrine Switzer 2Health News:Marc Anthony to Perform at "Nieves Productions" Latinos in Action Festival 2Health News:Founding Class of the KGI School of Pharmacy Formally Welcomed into the Profession at a Traditional White Coat Ceremony 2Health News:Scientists 'Rewrite' Bad Memories in Mice 2Health News:Scientists 'Rewrite' Bad Memories in Mice 3
... , , NEW ... July 29, 2009 the Company will report second quarter 2009 financial results before ... with the release, the Company will hold a conference call on Wednesday, July ... Executive Officer, and John Henry, Senior Vice President and Chief Financial Officer, will ...
... second quarter financial results - , , LAVAL, QC, ... DDSS ) today announced that it will host a ... (ET) to discuss its second quarter 2009 financial results. Labopharm ... release at approximately 7:00 a.m. the same day. , To ...
... , LOS ANGELES, July 27 ... recently hired Sanford Devries for the position of ... the role of CFO/Controller for various companies. He has special ... With Wellspring,s goals for expansion and growth, Sanford is ...
... Midbrook ... well-suited for use in hospitals and other medical facilities that are working to prevent infections. ... (Vocus) July 27, 2009 ... well as case carts and storage cabinets has begun to use copper alloys as ...
... ... is now available through leading cold laser retailer Cold Laser-Therapy-US. The new programmable cold laser ... available to the medical field. , ... Cape Girardeau, MO (PRWEB) July 27, 2009 - Cold laser equipment also ...
... , , PITTSBURGH, July ... the following response to a news article published earlier today: ... about an issue related to a Standard Operating Procedure (SOP) ... anonymous sources. Simply put, our investigation of the issue demonstrates ...
Cached Medicine News:Health News:Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET) 2Health News:Wellspring Hires Sanford Devries as Controller 2Health News:Midbrook Utilizes Copper in Medical Environments 2Health News:Cold Laser Technology Made Even More Accessible with Powerful New Product Available from Laser-Therapy.US 2
Microplate incubator shaker used in a variety of immunoassay and research procedures requiring microplates....
... especially suited for cell analysis and ... allows to analyze scatter signals in ... channels. Data acquisition, analysis, and real-time ... PC employing Partec DPAC software, built-in ...
This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
... The IMMULITE 1000 immunoassay system ... use, reliability, robust hardware and excellent ... onboard reagents and accommodates onboard dilutions, ... , , Worldwide, IMMULITE 1000 (and ...
Medicine Products: